<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240311061249N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-03-30</date_registration>
      <primary_sponsor>Bu-Ali Sina University, Hamedan</primary_sponsor>
      <public_title>The Effect of Trunk Motor Control Exercises Along with Pain Neuroscience Education in Patients with Non-Specific Chronic Low Back Pain</public_title>
      <acronym>CNSLBP</acronym>
      <scientific_title>The Effect of Trunk Motor Control Exercises Along with Pain Neuroscience Education in Water and Land Environment on Disability, Psychological Variables and Postural Control of Patients with Non-Specific Chronic Low Back Pain: A Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-01-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/75915</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: First, Random Codes will be Generated Using Random Allocation Software and then they will be Placed Inside Sealed Envelopes. An Evaluator who is not Aware of the Study Purpose will Randomly Deliver the Envelopes to the Patients. As a Result, Patients will be Assigned to Experimental and Control Groups (30 People in Each Group) with a 1:1:1 Allocation. Patients and Assessors will be Unaware of Group Allocation, Blinding description: First, Random Codes will be Generated Using Random Allocation Software and then they will be Placed Inside Sealed Envelopes. An Evaluator who is not Aware of the  Study Purpose will Randomly Deliver the Envelopes to the Patients. As a Result, Patients will be Assigned to Experimental and Control Groups (30 People in Each Group) with a 1:1:1 Allocation. Patients and Assessors will be Unaware of Group Allocation.</study_design>
      <phase>3</phase>
      <hc_freetext>Chronic Non-Specific Low Back Pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group: Motor Control Exercises in Four Weeks, 6 Sessions per Week (3 Sessions in the Swimming Pool of Bu-Ali Sina University and 3 Sessions in the Sports hall of Bu-Ali Sina University) Each Session will be done for 30 to 45 Minutes and the Neuroscience Education Includes 8 Topics  Along with Verbal Explanations be Presented for 10 Minutes before the Beginning of the Treatment Sessions. Intervention 2: Intervention Group: Motor Control Exercises will be done in Eight Weeks, (4 Weeks in Water and 4 Weeks on Land) Three Sessions per Week for 30 to 45 Minutes Each Session and Neuroscience Education Includes 8 Topics with Oral Explanations for 10 It will be Provided Minutes Before the Start of Treatment Sessions. Intervention 3: Control Group: They will not Receive any Intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All Data and Documents Can be Shared, but with the Non-Identification of People and the Preservation of Private Information of Subjects.

When:
The Results of this Study will be Available 3 Months after Publication in Journals.

To whom:
The Results of the Studies will be Accessible to all Members of the Society Without any Restrictions.

Conditions:
The Presented Documentation Can be Used for the Treatment of Non-Specific Chronic Low Back Pain. These Interventions are Applicable if they are Prescribed and Supervised by a Physiotherapist.

Where to obtain:
Fateme Soori's email Address is fatemesori1862@gmail.com

How to obtain:
When the Applicant Provides Documents for her Field of Work Related to the Subject of the Thesis and in Case of a Reasonable Request and a Commitment not to Misuse the Data of This Research, the Data will be Sent to her for 1 Working Week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Yalfani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Madani Town, Azadegan Street, 2 Yas Alley, Azin Building, Unit 8</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6513861328</zip>
        <telephone>+98 81 3429 6149</telephone>
        <email>fatemesori1862@gmail.com</email>
        <affiliation>Bu-Ali Sina University, Hamedan</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Yalfani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Madani Town, Azadegan Street, 2 Yas Alley, Azin Building, Unit 8</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6513861328</zip>
        <telephone>+98 81 3429 6149</telephone>
        <email>fatemesori1862@gmail.com</email>
        <affiliation>Bu-Ali Sina University, Hamedan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Suffering from Chronic Low Back Pain for More than 3 Months
The Cause of Low Back Pain is Unknown
Age Range from 30 to 60 Years
Pain Intensity more than 45 mm on the Visual Analog Scale
Oswestrian Disability Index More than 25</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>60 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Pain in other Joints
Misalignment of Upper and Lower Limbs
History of Surgery
Use of Painkillers in the Past 6 Months
Physiotherapy in the Last Year
Participate in Sports
Sciatica Pain
Spondylolysis
Neuromuscular Disorders
Neurological Disorder
Respiratory Disorders
Muscle Spasm
Vertebral Fractures</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low Back Pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Diagnosis</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group: Motor Control Exercises in Four Weeks, 6 Sessions per Week (3 Sessions in the Swimming Pool of Bu-Ali Sina University and 3 Sessions in the Sports hall of Bu-Ali Sina University) Each Session will be done for 30 to 45 Minutes and the Neuroscience Education Includes 8 Topics  Along with Verbal Explanations be Presented for 10 Minutes before the Beginning of the Treatment Sessions</i_keyword>
      <i_keyword>Intervention Group: Motor Control Exercises will be done in Eight Weeks, (4 Weeks in Water and 4 Weeks on Land) Three Sessions per Week for 30 to 45 Minutes Each Session and Neuroscience Education Includes 8 Topics with Oral Explanations for 10 It will be Provided Minutes Before the Start of Treatment Sessions.</i_keyword>
      <i_keyword>Control Group: They will not Receive any Intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain, Fear of Movement, Stress, Anxiety, Depression, Pain Catastrophizing. Timepoint: In this Clinical Trial, the Researcher Intends to Evaluate the Variables of Pain, Fear of Movement, Stress, Anxiety, Depression, Pain Catastrophizing in Two time Periods Before the Intervention (Pre-Test) and After the Intervention (4 and 8 Weeks). Method of measurement: Pain (Visual Analog Scale), Fear of Movement (Tampa Questionnaire), Stress, Anxiety and Depression (Stress, Anxiety and Depression Questionnaire), Pain Catastrophizing (Pain Catastrophizing Questionnaire).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Disability, Postural Control, Plantar Pressure Distribution, Vertical Ground Reaction Force. Timepoint: In this Clinical trial, the Researcher Intends to Evaluate Disability Variables, Posture Control, Plantar Pressure Distribution, Vertical Ground Reaction Force in two time Periods before the Intervention (Pre-Test) and after the Intervention (4 and 8 Weeks). Method of measurement: Disability (Oswestory Questionnaire), Posture Control, Plantar Pressure Distribution and Vertical Ground Reaction Force (Foot Pressure).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>There is no source of financial support.</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-03-09</approval_date>
        <contact_name>کمیته اخلاق دانشگاه بوعلی سینا</contact_name>
        <contact_address>Madani Town, Azadegan Street, 2 Yas Alley, Azin Building, Unit 8 Hamedan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
